Skip to main content
. Author manuscript; available in PMC: 2014 Jul 16.
Published in final edited form as: Psychol Med. 2012 Feb 28;42(10):2109–2118. doi: 10.1017/S0033291712000268

Table 3.

Mental disorders as risk factors for first onset of suicidality in Lebanona

Disorder Unadjusted for co-morbidity
Adjusted for co-morbidity
Ideation
Plan
Attempt
Ideation
Plan
Attempt
(95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
I. Anxiety disorders
 Panic disorder 9.5* (1.1–81.7)
 Generalized anxiety disorder 7.2* (1.9–27.0) 4.3 (0.5–36.5) 8.3* (1.9–35.5) 3.0 (0.8–11.0) 1.1 (0.1–11.0) 2.7 (0.6–11.3)
 Specific phobia 1.7 (0.8–3.3) 2.1 (0.8–5.5) 2.0 (0.9–4.7) 0.7 (0.2–2.8) 1.1 (0.2–4.9) 1.5 (0.4–5.2)
 Social phobia 9.5* (2.8–32.6) 13.2* (2.2–80.8) 5.0* (1.4–18.0) 10.5* (2.2–48.8) 11.5* (1.5–85.4) 3.7 (0.9–15.6)c
 Posttraumatic stress disorder 2.5 (0.5–11.7) 5.9* (1.1–31.3) 4.6* (1.0–20.8) 0.8 (0.1–4.2) 1.0 (0.1–9.1) 1.5 (0.3–7.3)
 Separation anxietyb 2.2 (0.8–5.6) 3.9* (1.4–10.8) 2.0 (0.6–6.6) 1.2 (0.5–2.7) 2.0 (0.8–5.1) 0.9 (0.3–2.8)
 Any anxiety disorders 3.8* (2.1–6.8) 6.4* (2.8–14.8) 3.5* (1.9–6.2)
II. Mood disorders
 Major depressive disorder 10.3* (5.1–21.0) 19.5* (9.2–41.1) 10.4* (4.8–22.3) 7.5* (3.6–15.5) 10.6* (4.6–24.3) 7.1* (3.6–13.9)
 Dysthymia 11.5* (3.0–44.0) 30.6* (6.6–141.6) 12.2* (1.7–86.0) 2.1 (0.5–9.11) 2.8 (0.4–22.4) 2.4 (0.3–19.0)
 Bipolar disorder 2.3 (0.5–10.4) 4.3 (0.6–29.0) 3.7 (0.6–21.1) 0.8 (0.1–5.1) 1.5 (0.2–15.6) 1.2 (0.1–11.4)
 Any mood disorders 8.1* (4.3–15.3) 15.9* (8.4–30.2) 8.7* (4.5–16.7)
III. Any impulse-control disorderb 12.7* (4.9–33.0) 17.8* (5.3–59.5) 14.4* (3.7–55.7) 11.0* (4.5–26.6) 9.5* (1.9–48.8) 10.0* (2.4–41.8)
IV. Any substance use disorder 6.1* (1.1–33.0) 14.3* (1.8–115.4) 21.0* (4.8–92.2) 2.0 (0.5–8.0) 4.0 (0.7–22.8) 5.2 (0.8–31.3)c
V. Any disorder 5.9* (3.6–9.4) 10.0* (4.5–22.2) 4.7* (2.5–8.6)

OR, Odds ratio ; CI, confidence interval.

Insufficient cases, but included as one of the disorders in the ‘Any’ category.

– Not assessed in models adjusted for comorbidity.

a

Discrete time survival models, assessed for respondents who completed part II (n=1031) controlling for sociodemographic variables (age, sex, education, marital status).

b

Assessed within age range 18–44 years.

c

Borderline significance : p=0.08 for social phobia and p=0.07 for substance use disorders.

*

Significant at the 0.05 level, two-sided test.